Efficacy of mirtazapine in clinically relevant subgroups of depressed patients

Depression and Anxiety

Volumn 7, Issue SUPPL. 1, 1998, Pages 7-10

  Nutt, D J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anxiety; Depression; Efficacy; Mirtazapine; Sleep disturbance

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; AMITRIPTYLINE; CLOMIPRAMINE; DOXEPIN; FLUOXETINE; MIRTAZAPINE; SEROTONIN RECEPTOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY NEUROSIS; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; HAMILTON SCALE; HUMAN; META ANALYSIS; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; CLINICAL TRIALS; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; MIANSERIN; NOREPINEPHRINE; SEROTONIN; TREATMENT OUTCOME;

EID: 0031980873     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)7:1+<7::AID-DA3>3.0.CO;2-2     Document Type: Review

References (9)

1. Cleary P, Guy W (1977) Factor analysis of the Hamilton Depression Scale. Drugs Expl Clin Res 1.115-120.
2. de Boer T (1995) The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol 10 (Suppl 4): 19-23.
3. de Boer T (1996) The pharmacologic profile of mirtazapine. J Clin Psychiatr 57 (Suppl 4):19-25.
4. 2 antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 253:R5-6.
5. 2 selective adrenoceptor antagonist Org 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Hum Psychopharmacol 10 (Suppl 2): S107-S109.
6. Kasper S (1995) Clinical efficacy of mirtazapine: A review of meta-analyses on pooled data. Int Clin Psychopharmacol 10 (Suppl 4). 25-35.
7. Montgomery SA (1995) Safety of mirtazapine: A review. Int Clin Psychopharmacol 10 (Suppl 4): 39-47.
8. Nutt D (1997) Mirtazapine: Pharmacology in relation to adverse effects. Acta Psychiatr Scand 96 (Suppl 391): 31-37.
9. Wheatley D, Kremer CMF, (1997) A randomized, double-blind comparison of mirtazapine and fluoxetine in patients with major depression. Annual Meeting of the American Psychiatric Association, San Diego, Ca, May 17-22, 1997, New Research Program & Abstracts, p124.